Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Retained Earnings: 2019-2025

Historic Retained Earnings for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $138.4 million.

  • Harmony Biosciences Holdings' Retained Earnings rose 392.89% to $138.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.4 million, marking a year-over-year increase of 392.89%. This contributed to the annual value of $2.2 million for FY2024, which is 101.55% up from last year.
  • Harmony Biosciences Holdings' Retained Earnings amounted to $138.4 million in Q3 2025, which was up 58.10% from $87.6 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Retained Earnings ranged from a high of $138.4 million in Q3 2025 and a low of -$480.8 million during Q1 2021.
  • Over the past 3 years, Harmony Biosciences Holdings' median Retained Earnings value was -$93.4 million (recorded in 2024), while the average stood at -$66.7 million.
  • Data for Harmony Biosciences Holdings' Retained Earnings shows a peak YoY spiked of 392.89% (in 2025) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Retained Earnings (Quarterly) stood at -$453.6 million in 2021, then surged by 40.01% to -$272.1 million in 2022, then soared by 47.35% to -$143.3 million in 2023, then surged by 101.55% to $2.2 million in 2024, then skyrocketed by 392.89% to $138.4 million in 2025.
  • Its last three reported values are $138.4 million in Q3 2025, $87.6 million for Q2 2025, and $47.8 million during Q1 2025.